TC
CLB icon

TownSquare Capital’s Core Laboratories CLB Stock Holding History

TownSquare Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-70,606
Closed -$1.43M – 1494
2024
Q2 		$1.43M Buy
70,606
+9,786
+16% +$173K 0.02% 586
2024
Q1 		$1.04M Buy
60,820
+17,420
+40% +$274K 0.02% 646
2023
Q4 		$766K Buy
43,400
+8,940
+26% +$180K 0.01% 668
2023
Q3 		$827K Buy
34,460
+8,959
+35% +$220K 0.02% 613
2023
Q2 		$593K Buy
25,501
+4,062
+19% +$91.9K 0.01% 715
2023
Q1 		$473K Buy
21,439
+4,289
+25% +$100K 0.01% 693
2022
Q4 		$348K Buy
17,150
+2,831
+20% +$54.9K 0.01% 761
2022
Q3 		$193K Buy
+14,319
New +$241K 0.01% 699

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TownSquare Capital's CLB Position: Q3 2024 in Review

TownSquare Capital sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 70,606 shares — an estimated $1.43M sold.

TownSquare Capital first reported a position in CLB in Q3 2022 and held it in 8 quarters. The position peaked at $1.43M in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • TownSquare Capital reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • TownSquare Capital sold 70,606 Core Laboratories shares in Q3 2024, an estimated $1.43M.
  • TownSquare Capital first reported a position in Core Laboratories in Q3 2022 and held it in 8 quarters.
  • TownSquare Capital's Core Laboratories position peaked at $1.43M in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on TownSquare Capital's 13F filing for Q3 2024, filed 13 Nov 2024.